JSP191 (briquilimab) in Subjects with LR-MDS

NCT05903274 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
6
Enrollment
INDUSTRY
Sponsor class

Stopped The study was terminated due to a lack of improvement in clinical efficacy outcomes.

Conditions

Interventions

Sponsor

Jasper Therapeutics, Inc.